Edith Kealey1, Sarah Hudson Scholle2, Sepheen C Byron2, Kimberly Hoagwood3, Emily Leckman-Westin4, Kelly Kelleher5, Molly Finnerty6. 1. New York State Office of Mental Health, New York, NY. 2. National Committee for Quality Assurance, Washington, DC. 3. Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York, NY. 4. New York State Office of Mental Health, New York, NY; New York State Office of Mental Health and School of Public Health, State University of New York-Albany, Albany, NY. 5. Department of Pediatrics, The Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, Ohio. 6. New York State Office of Mental Health, New York, NY; Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York, NY. Electronic address: molly.finnerty@omh.ny.gov.
Abstract
BACKGROUND: Antipsychotic prescribing for youth has increased rapidly, is linked with serious health concerns, and lacks clear measures of quality for pediatric care. We reviewed treatment guidelines relevant to 7 quality concepts for appropriate use and management of youth on antipsychotics: 1) use in very young children, 2) multiple concurrent antipsychotics, 3) higher-than-recommended doses, 4) use without a primary indication, 5) access to psychosocial interventions, 6) metabolic screening, and 7) follow-up visits with a prescriber. METHODS: We searched for clinical practice guidelines meeting the following criteria: developed or endorsed by a national body, published after 2000, and specific treatment recommendations made related to 1 or more of the 7 quality concepts. Sources included electronic databases, the American Academy of Child and Adolescent Psychiatry Web site, and stakeholder and expert advisory committee recommendations. Two raters reviewed the 11 guidelines identified, extracting treatment recommendations, including details that could support measure definitions, and ratings of strength of recommendation and evidence. RESULTS: All 7 quality concepts were strongly endorsed by 1 or more guidelines, and 2 or more guidelines assigned their highest strength of recommendation ratings to 6 of the 7 concepts. Two guidelines rated evidence, providing high strength of evidence for 2 quality concepts: psychosocial interventions and metabolic monitoring. CONCLUSIONS: Guidelines provide support for 7 quality concepts addressing antipsychotic prescribing for youth. However, guideline support is often based on strong clinical consensus rather than a robust evidence base.
BACKGROUND: Antipsychotic prescribing for youth has increased rapidly, is linked with serious health concerns, and lacks clear measures of quality for pediatric care. We reviewed treatment guidelines relevant to 7 quality concepts for appropriate use and management of youth on antipsychotics: 1) use in very young children, 2) multiple concurrent antipsychotics, 3) higher-than-recommended doses, 4) use without a primary indication, 5) access to psychosocial interventions, 6) metabolic screening, and 7) follow-up visits with a prescriber. METHODS: We searched for clinical practice guidelines meeting the following criteria: developed or endorsed by a national body, published after 2000, and specific treatment recommendations made related to 1 or more of the 7 quality concepts. Sources included electronic databases, the American Academy of Child and Adolescent Psychiatry Web site, and stakeholder and expert advisory committee recommendations. Two raters reviewed the 11 guidelines identified, extracting treatment recommendations, including details that could support measure definitions, and ratings of strength of recommendation and evidence. RESULTS: All 7 quality concepts were strongly endorsed by 1 or more guidelines, and 2 or more guidelines assigned their highest strength of recommendation ratings to 6 of the 7 concepts. Two guidelines rated evidence, providing high strength of evidence for 2 quality concepts: psychosocial interventions and metabolic monitoring. CONCLUSIONS: Guidelines provide support for 7 quality concepts addressing antipsychotic prescribing for youth. However, guideline support is often based on strong clinical consensus rather than a robust evidence base.
Authors: Nancy Scotto Rosato; Christoph U Correll; Elizabeth Pappadopulos; Alanna Chait; Stephen Crystal; Peter S Jensen Journal: Pediatrics Date: 2012-05-28 Impact factor: 7.124
Authors: Mary Margaret Gleason; Helen Link Egger; Graham J Emslie; Laurence L Greenhill; Robert A Kowatch; Alicia F Lieberman; Joan L Luby; Judith Owens; Lawrence D Scahill; Michael S Scheeringa; Brian Stafford; Brian Wise; Charles H Zeanah Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-12 Impact factor: 8.829
Authors: Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann Journal: BMJ Date: 2008-04-26
Authors: Bonnie T Zima; J Michael Murphy; Sarah Hudson Scholle; Kimberly Eaton Hoagwood; Ramesh C Sachdeva; Rita Mangione-Smith; Donna Woods; Hayley S Kamin; Michael Jellinek Journal: Pediatrics Date: 2013-03 Impact factor: 7.124
Authors: Robert B Penfold; Christine Stewart; Enid M Hunkeler; Jeanne M Madden; Janet R Cummings; Ashli A Owen-Smith; Rebecca C Rossom; Christine Y Lu; Frances L Lynch; Beth E Waitzfelder; Karen J Coleman; Karen A Coleman; Brian K Ahmedani; Arne L Beck; John E Zeber; Gregory E Simon Journal: Curr Psychiatry Rep Date: 2013-12 Impact factor: 5.285
Authors: Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra Journal: JAMA Date: 2009-10-28 Impact factor: 56.272
Authors: Sepheen C Byron; William Gardner; Lawrence C Kleinman; Rita Mangione-Smith; JeanHee Moon; Ramesh Sachdeva; Mark A Schuster; Gary L Freed; Gwen Smith; Sarah Hudson Scholle Journal: Acad Pediatr Date: 2014 Sep-Oct Impact factor: 3.107
Authors: Haiden A Huskamp; Marcela Horvitz-Lennon; Ernst R Berndt; Sharon-Lise T Normand; Julie M Donohue Journal: Psychiatr Serv Date: 2016-07-15 Impact factor: 3.084
Authors: Kimberly Eaton Hoagwood; Susan Essock; Joseph Morrissey; Anne Libby; Sheila Donahue; Benjamin Druss; Molly Finnerty; Linda Frisman; Meera Narasimhan; Bradley D Stein; Jennifer Wisdom; Judy Zerzan Journal: Adm Policy Ment Health Date: 2016-01